APO Research
Talk to an analyst

APO RESEARCH · REPORT

Liver Cirrhosis Therapeutics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Liver Cirrhosis Therapeutics Market Analysis and Forecast 2026-2032

20 December 2025197 pages

Choose your research edition.

Industry ResearchLiver Cirrhosis Therapeutics Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Liver Cirrhosis Therapeutics Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Liver Cirrhosis Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Liver Cirrhosis Therapeutics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Liver Cirrhosis Therapeutics Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Liver Cirrhosis Therapeutics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Liver Cirrhosis Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Liver Cirrhosis Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Liver Cirrhosis Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Liver Cirrhosis Therapeutics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Liver Cirrhosis Therapeutics include Bristol-Myers Squibb, Conatus Pharmaceuticals, Gilead Sciences, Gwo Xi Stem Cell Applied Technology, Instituto Grifols, Intercept Pharmaceuticals, NGM Biopharmaceuticals, Norgine and Pharmicell, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Liver Cirrhosis Therapeutics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Liver Cirrhosis Therapeutics, also provides the sales of main regions and countries. Of the upcoming market potential for Liver Cirrhosis Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Liver Cirrhosis Therapeutics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Liver Cirrhosis Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Liver Cirrhosis Therapeutics sales, projected growth trends, production technology, application and end-user industry.

Liver Cirrhosis Therapeutics Segment by Company

Bristol-Myers Squibb

Conatus Pharmaceuticals

Gilead Sciences

Gwo Xi Stem Cell Applied Technology

Instituto Grifols

Intercept Pharmaceuticals

NGM Biopharmaceuticals

Norgine

Pharmicell

Salix Pharmaceuticals

Stempeutics Research

GlaxoSmithKline

Roche

Merck

Johnson & Johnson

Liver Cirrhosis Therapeutics Segment by Type

Oral Liver Cirrhosis Therapeutics Drugs

Injection Liver Cirrhosis Therapeutics Drugs

Liver Cirrhosis Therapeutics Segment by Application

Hospitals

Clinics

Other

Liver Cirrhosis Therapeutics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Liver Cirrhosis Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Liver Cirrhosis Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Liver Cirrhosis Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Liver Cirrhosis Therapeutics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Liver Cirrhosis Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Cirrhosis Therapeutics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Liver Cirrhosis Therapeutics Drugs Major Manufacturers Table 3. Injection Liver Cirrhosis Therapeutics Drugs Major Manufacturers Table 4. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Other Major Manufacturers Table 8. Liver Cirrhosis Therapeutics Industry Trends Table 9. Liver Cirrhosis Therapeutics Industry Drivers Table 10. Liver Cirrhosis Therapeutics Industry Opportunities and Challenges Table 11. Liver Cirrhosis Therapeutics Industry Restraints Table 12. Global Liver Cirrhosis Therapeutics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Liver Cirrhosis Therapeutics Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Liver Cirrhosis Therapeutics Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2021-2026) Table 16. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2027-2032) Table 17. Global Liver Cirrhosis Therapeutics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Units) Table 18. Global Liver Cirrhosis Therapeutics Sales by Region (2021-2026) & (W Units) Table 19. Global Liver Cirrhosis Therapeutics Sales by Region (2027-2032) & (W Units) Table 20. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2021-2026) Table 21. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2027-2032) Table 22. Global Liver Cirrhosis Therapeutics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Liver Cirrhosis Therapeutics Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Liver Cirrhosis Therapeutics Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Liver Cirrhosis Therapeutics Sales Market Share by Manufacturers (2021-2026) Table 26. Global Liver Cirrhosis Therapeutics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Liver Cirrhosis Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Liver Cirrhosis Therapeutics Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Liver Cirrhosis Therapeutics Manufacturers, Product Type & Application Table 30. Global Liver Cirrhosis Therapeutics Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Liver Cirrhosis Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Liver Cirrhosis Therapeutics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Liver Cirrhosis Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Liver Cirrhosis Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2021-2026) Table 37. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2027-2032) Table 38. Global Liver Cirrhosis Therapeutics Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 39. Global Liver Cirrhosis Therapeutics Sales by Type (2021-2026) & (W Units) Table 40. Global Liver Cirrhosis Therapeutics Sales by Type (2027-2032) & (W Units) Table 41. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2021-2026) Table 42. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2027-2032) Table 43. Global Liver Cirrhosis Therapeutics Price by Type (2021-2026) & (US$/Unit) Table 44. Global Liver Cirrhosis Therapeutics Price by Type (2027-2032) & (US$/Unit) Table 45. Global Liver Cirrhosis Therapeutics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Liver Cirrhosis Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Liver Cirrhosis Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2021-2026) Table 49. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2027-2032) Table 50. Global Liver Cirrhosis Therapeutics Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 51. Global Liver Cirrhosis Therapeutics Sales by Application (2021-2026) & (W Units) Table 52. Global Liver Cirrhosis Therapeutics Sales by Application (2027-2032) & (W Units) Table 53. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2021-2026) Table 54. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2027-2032) Table 55. Global Liver Cirrhosis Therapeutics Price by Application (2021-2026) & (US$/Unit) Table 56. Global Liver Cirrhosis Therapeutics Price by Application (2027-2032) & (US$/Unit) Table 57. Bristol-Myers Squibb Company Information Table 58. Bristol-Myers Squibb Business Overview Table 59. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product Portfolio Table 61. Bristol-Myers Squibb Recent Development Table 62. Conatus Pharmaceuticals Company Information Table 63. Conatus Pharmaceuticals Business Overview Table 64. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 66. Conatus Pharmaceuticals Recent Development Table 67. Gilead Sciences Company Information Table 68. Gilead Sciences Business Overview Table 69. Gilead Sciences Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Gilead Sciences Liver Cirrhosis Therapeutics Product Portfolio Table 71. Gilead Sciences Recent Development Table 72. Gwo Xi Stem Cell Applied Technology Company Information Table 73. Gwo Xi Stem Cell Applied Technology Business Overview Table 74. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product Portfolio Table 76. Gwo Xi Stem Cell Applied Technology Recent Development Table 77. Instituto Grifols Company Information Table 78. Instituto Grifols Business Overview Table 79. Instituto Grifols Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Instituto Grifols Liver Cirrhosis Therapeutics Product Portfolio Table 81. Instituto Grifols Recent Development Table 82. Intercept Pharmaceuticals Company Information Table 83. Intercept Pharmaceuticals Business Overview Table 84. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 86. Intercept Pharmaceuticals Recent Development Table 87. NGM Biopharmaceuticals Company Information Table 88. NGM Biopharmaceuticals Business Overview Table 89. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 91. NGM Biopharmaceuticals Recent Development Table 92. Norgine Company Information Table 93. Norgine Business Overview Table 94. Norgine Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Norgine Liver Cirrhosis Therapeutics Product Portfolio Table 96. Norgine Recent Development Table 97. Pharmicell Company Information Table 98. Pharmicell Business Overview Table 99. Pharmicell Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Pharmicell Liver Cirrhosis Therapeutics Product Portfolio Table 101. Pharmicell Recent Development Table 102. Salix Pharmaceuticals Company Information Table 103. Salix Pharmaceuticals Business Overview Table 104. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio Table 106. Salix Pharmaceuticals Recent Development Table 107. Stempeutics Research Company Information Table 108. Stempeutics Research Business Overview Table 109. Stempeutics Research Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Stempeutics Research Liver Cirrhosis Therapeutics Product Portfolio Table 111. Stempeutics Research Recent Development Table 112. GlaxoSmithKline Company Information Table 113. GlaxoSmithKline Business Overview Table 114. GlaxoSmithKline Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. GlaxoSmithKline Liver Cirrhosis Therapeutics Product Portfolio Table 116. GlaxoSmithKline Recent Development Table 117. Roche Company Information Table 118. Roche Business Overview Table 119. Roche Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Roche Liver Cirrhosis Therapeutics Product Portfolio Table 121. Roche Recent Development Table 122. Merck Company Information Table 123. Merck Business Overview Table 124. Merck Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Merck Liver Cirrhosis Therapeutics Product Portfolio Table 126. Merck Recent Development Table 127. Johnson & Johnson Company Information Table 128. Johnson & Johnson Business Overview Table 129. Johnson & Johnson Liver Cirrhosis Therapeutics Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Johnson & Johnson Liver Cirrhosis Therapeutics Product Portfolio Table 131. Johnson & Johnson Recent Development Table 132. North America Liver Cirrhosis Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 133. North America Liver Cirrhosis Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 134. North America Liver Cirrhosis Therapeutics Sales by Type (2021-2026) & (W Units) Table 135. North America Liver Cirrhosis Therapeutics Sales by Type (2027-2032) & (W Units) Table 136. North America Liver Cirrhosis Therapeutics Sales Price by Type (2021-2026) & (US$/Unit) Table 137. North America Liver Cirrhosis Therapeutics Sales Price by Type (2027-2032) & (US$/Unit) Table 138. North America Liver Cirrhosis Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 139. North America Liver Cirrhosis Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 140. North America Liver Cirrhosis Therapeutics Sales by Application (2021-2026) & (W Units) Table 141. North America Liver Cirrhosis Therapeutics Sales by Application (2027-2032) & (W Units) Table 142. North America Liver Cirrhosis Therapeutics Sales Price by Application (2021-2026) & (US$/Unit) Table 143. North America Liver Cirrhosis Therapeutics Sales Price by Application (2027-2032) & (US$/Unit) Table 144. North America Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. North America Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. North America Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. North America Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 148. North America Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 149. North America Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 150. North America Liver Cirrhosis Therapeutics Sales Price by Country (2021-2026) & (US$/Unit) Table 151. North America Liver Cirrhosis Therapeutics Sales Price by Country (2027-2032) & (US$/Unit) Table 152. United States Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 153. Canada Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 154. Europe Liver Cirrhosis Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 155. Europe Liver Cirrhosis Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 156. Europe Liver Cirrhosis Therapeutics Sales by Type (2021-2026) & (W Units) Table 157. Europe Liver Cirrhosis Therapeutics Sales by Type (2027-2032) & (W Units) Table 158. Europe Liver Cirrhosis Therapeutics Sales Price by Type (2021-2026) & (US$/Unit) Table 159. Europe Liver Cirrhosis Therapeutics Sales Price by Type (2027-2032) & (US$/Unit) Table 160. Europe Liver Cirrhosis Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 161. Europe Liver Cirrhosis Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 162. Europe Liver Cirrhosis Therapeutics Sales by Application (2021-2026) & (W Units) Table 163. Europe Liver Cirrhosis Therapeutics Sales by Application (2027-2032) & (W Units) Table 164. Europe Liver Cirrhosis Therapeutics Sales Price by Application (2021-2026) & (US$/Unit) Table 165. Europe Liver Cirrhosis Therapeutics Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Europe Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Europe Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Europe Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Europe Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 170. Europe Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 171. Europe Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 172. Europe Liver Cirrhosis Therapeutics Sales Price by Country (2021-2026) & (US$/Unit) Table 173. Europe Liver Cirrhosis Therapeutics Sales Price by Country (2027-2032) & (US$/Unit) Table 174. Germany Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 175. France Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 176. U.K. Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 177. Italy Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 178. Netherlands Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 179. Nordic Countries Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 180. China Liver Cirrhosis Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 181. China Liver Cirrhosis Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 182. China Liver Cirrhosis Therapeutics Sales by Type (2021-2026) & (W Units) Table 183. China Liver Cirrhosis Therapeutics Sales by Type (2027-2032) & (W Units) Table 184. China Liver Cirrhosis Therapeutics Sales Price by Type (2021-2026) & (US$/Unit) Table 185. China Liver Cirrhosis Therapeutics Sales Price by Type (2027-2032) & (US$/Unit) Table 186. China Liver Cirrhosis Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 187. China Liver Cirrhosis Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 188. China Liver Cirrhosis Therapeutics Sales by Application (2021-2026) & (W Units) Table 189. China Liver Cirrhosis Therapeutics Sales by Application (2027-2032) & (W Units) Table 190. China Liver Cirrhosis Therapeutics Sales Price by Application (2021-2026) & (US$/Unit) Table 191. China Liver Cirrhosis Therapeutics Sales Price by Application (2027-2032) & (US$/Unit) Table 192. Asia Liver Cirrhosis Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 193. Asia Liver Cirrhosis Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 194. Asia Liver Cirrhosis Therapeutics Sales by Type (2021-2026) & (W Units) Table 195. Asia Liver Cirrhosis Therapeutics Sales by Type (2027-2032) & (W Units) Table 196. Asia Liver Cirrhosis Therapeutics Sales Price by Type (2021-2026) & (US$/Unit) Table 197. Asia Liver Cirrhosis Therapeutics Sales Price by Type (2027-2032) & (US$/Unit) Table 198. Asia Liver Cirrhosis Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 199. Asia Liver Cirrhosis Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 200. Asia Liver Cirrhosis Therapeutics Sales by Application (2021-2026) & (W Units) Table 201. Asia Liver Cirrhosis Therapeutics Sales by Application (2027-2032) & (W Units) Table 202. Asia Liver Cirrhosis Therapeutics Sales Price by Application (2021-2026) & (US$/Unit) Table 203. Asia Liver Cirrhosis Therapeutics Sales Price by Application (2027-2032) & (US$/Unit) Table 204. Asia Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. Asia Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. Asia Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. Asia Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 208. Asia Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 209. Asia Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 210. Asia Liver Cirrhosis Therapeutics Sales Price by Country (2021-2026) & (US$/Unit) Table 211. Asia Liver Cirrhosis Therapeutics Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Japan Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 213. South Korea Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 214. India Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 215. Australia Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 216. China Taiwan Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 217. Southeast Asia Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 218. SAMEA Liver Cirrhosis Therapeutics Revenue by Type (2021-2026) & (US$ Million) Table 219. SAMEA Liver Cirrhosis Therapeutics Revenue by Type (2027-2032) & (US$ Million) Table 220. SAMEA Liver Cirrhosis Therapeutics Sales by Type (2021-2026) & (W Units) Table 221. SAMEA Liver Cirrhosis Therapeutics Sales by Type (2027-2032) & (W Units) Table 222. SAMEA Liver Cirrhosis Therapeutics Sales Price by Type (2021-2026) & (US$/Unit) Table 223. SAMEA Liver Cirrhosis Therapeutics Sales Price by Type (2027-2032) & (US$/Unit) Table 224. SAMEA Liver Cirrhosis Therapeutics Revenue by Application (2021-2026) & (US$ Million) Table 225. SAMEA Liver Cirrhosis Therapeutics Revenue by Application (2027-2032) & (US$ Million) Table 226. SAMEA Liver Cirrhosis Therapeutics Sales by Application (2021-2026) & (W Units) Table 227. SAMEA Liver Cirrhosis Therapeutics Sales by Application (2027-2032) & (W Units) Table 228. SAMEA Liver Cirrhosis Therapeutics Sales Price by Application (2021-2026) & (US$/Unit) Table 229. SAMEA Liver Cirrhosis Therapeutics Sales Price by Application (2027-2032) & (US$/Unit) Table 230. SAMEA Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 231. SAMEA Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 232. SAMEA Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 233. SAMEA Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032) & (W Units) Table 234. SAMEA Liver Cirrhosis Therapeutics Sales by Country (2021-2026) & (W Units) Table 235. SAMEA Liver Cirrhosis Therapeutics Sales by Country (2027-2032) & (W Units) Table 236. SAMEA Liver Cirrhosis Therapeutics Sales Price by Country (2021-2026) & (US$/Unit) Table 237. SAMEA Liver Cirrhosis Therapeutics Sales Price by Country (2027-2032) & (US$/Unit) Table 238. Brazil Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 239. Argentina Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 240. Chile Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 241. Colombia Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 242. Peru Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 243. Saudi Arabia Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 244. Israel Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 245. UAE Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 246. Turkey Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 247. Iran Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 248. Egypt Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Table 249. Key Raw Materials Table 250. Raw Materials Key Suppliers Table 251. Liver Cirrhosis Therapeutics Distributors List Table 252. Liver Cirrhosis Therapeutics Customers List Table 253. Research Programs/Design for This Report Table 254. Authors List of This Report Table 255. Secondary Sources Table 256. Primary Sources List of Figures Figure 1. Liver Cirrhosis Therapeutics Image Figure 2. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Liver Cirrhosis Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Liver Cirrhosis Therapeutics Drugs Image Figure 5. Injection Liver Cirrhosis Therapeutics Drugs Image Figure 6. Global Liver Cirrhosis Therapeutics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Liver Cirrhosis Therapeutics Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Other Image Figure 11. Global Liver Cirrhosis Therapeutics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Liver Cirrhosis Therapeutics Revenue (2021-2032) & (US$ Million) Figure 13. Global Liver Cirrhosis Therapeutics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2021-2032) Figure 16. Global Liver Cirrhosis Therapeutics Sales (2021-2032) & (W Units) Figure 17. Global Liver Cirrhosis Therapeutics Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 18. Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Liver Cirrhosis Therapeutics Sales YoY (2021-2032) & (W Units) Figure 20. Europe Liver Cirrhosis Therapeutics Sales YoY (2021-2032) & (W Units) Figure 21. China Liver Cirrhosis Therapeutics Sales YoY (2021-2032) & (W Units) Figure 22. Asia (Excluding China) Liver Cirrhosis Therapeutics Sales YoY (2021-2032) & (W Units) Figure 23. South America, Middle East and Africa Liver Cirrhosis Therapeutics Sales YoY (2021-2032) & (W Units) Figure 24. Global Liver Cirrhosis Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Liver Cirrhosis Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Liver Cirrhosis Therapeutics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2021-2032) Figure 30. Global Liver Cirrhosis Therapeutics Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 31. Global Liver Cirrhosis Therapeutics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2021-2032) Figure 33. Global Liver Cirrhosis Therapeutics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2021-2032) Figure 36. Global Liver Cirrhosis Therapeutics Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 37. Global Liver Cirrhosis Therapeutics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2021-2032) Figure 39. North America Liver Cirrhosis Therapeutics Revenue Share by Type (2021-2032) Figure 40. North America Liver Cirrhosis Therapeutics Sales Share by Type (2021-2032) Figure 41. North America Liver Cirrhosis Therapeutics Revenue Share by Application (2021-2032) Figure 42. North America Liver Cirrhosis Therapeutics Sales Share by Application (2021-2032) Figure 43. North America Liver Cirrhosis Therapeutics Revenue Share by Country (2021-2032) Figure 44. North America Liver Cirrhosis Therapeutics Sales Share by Country (2021-2032) Figure 45. Europe Liver Cirrhosis Therapeutics Revenue Share by Type (2021-2032) Figure 46. Europe Liver Cirrhosis Therapeutics Sales Share by Type (2021-2032) Figure 47. Europe Liver Cirrhosis Therapeutics Revenue Share by Application (2021-2032) Figure 48. Europe Liver Cirrhosis Therapeutics Sales Share by Application (2021-2032) Figure 49. Europe Liver Cirrhosis Therapeutics Revenue Share by Country (2021-2032) Figure 50. Europe Liver Cirrhosis Therapeutics Sales Share by Country (2021-2032) Figure 51. China Liver Cirrhosis Therapeutics Revenue Share by Type (2021-2032) Figure 52. China Liver Cirrhosis Therapeutics Sales Share by Type (2021-2032) Figure 53. China Liver Cirrhosis Therapeutics Revenue Share by Application (2021-2032) Figure 54. China Liver Cirrhosis Therapeutics Sales Share by Application (2021-2032) Figure 55. Asia Liver Cirrhosis Therapeutics Revenue Share by Type (2021-2032) Figure 56. Asia Liver Cirrhosis Therapeutics Sales Share by Type (2021-2032) Figure 57. Asia Liver Cirrhosis Therapeutics Revenue Share by Application (2021-2032) Figure 58. Asia Liver Cirrhosis Therapeutics Sales Share by Application (2021-2032) Figure 59. Asia Liver Cirrhosis Therapeutics Revenue Share by Country (2021-2032) Figure 60. Asia Liver Cirrhosis Therapeutics Sales Share by Country (2021-2032) Figure 61. SAMEA Liver Cirrhosis Therapeutics Revenue Share by Type (2021-2032) Figure 62. SAMEA Liver Cirrhosis Therapeutics Sales Share by Type (2021-2032) Figure 63. SAMEA Liver Cirrhosis Therapeutics Revenue Share by Application (2021-2032) Figure 64. SAMEA Liver Cirrhosis Therapeutics Sales Share by Application (2021-2032) Figure 65. SAMEA Liver Cirrhosis Therapeutics Revenue Share by Country (2021-2032) Figure 66. SAMEA Liver Cirrhosis Therapeutics Sales Share by Country (2021-2032) Figure 67. Liver Cirrhosis Therapeutics Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Liver Cirrhosis Therapeutics Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Liver Cirrhosis Therapeutics Drugs
  • Injection Liver Cirrhosis Therapeutics Drugs
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • Bristol-Myers Squibb
  • Conatus Pharmaceuticals
  • Gilead Sciences
  • Gwo Xi Stem Cell Applied Technology
  • Instituto Grifols
  • Intercept Pharmaceuticals
  • NGM Biopharmaceuticals
  • Norgine
  • Pharmicell
  • Salix Pharmaceuticals
  • Stempeutics Research
  • GlaxoSmithKline
  • Roche
  • Merck
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Liver Cirrhosis Therapeutics Market by Type
  3. 1.2.1 Global Liver Cirrhosis Therapeutics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral Liver Cirrhosis Therapeutics Drugs
  5. 1.2.3 Injection Liver Cirrhosis Therapeutics Drugs
  6. 1.3 Liver Cirrhosis Therapeutics Market by Application
  7. 1.3.1 Global Liver Cirrhosis Therapeutics Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Liver Cirrhosis Therapeutics Market Dynamics
  1. 2.1 Liver Cirrhosis Therapeutics Industry Trends
  2. 2.2 Liver Cirrhosis Therapeutics Industry Drivers
  3. 2.3 Liver Cirrhosis Therapeutics Industry Opportunities and Challenges
  4. 2.4 Liver Cirrhosis Therapeutics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Liver Cirrhosis Therapeutics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Liver Cirrhosis Therapeutics Revenue by Region
  3. 3.2.1 Global Liver Cirrhosis Therapeutics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Liver Cirrhosis Therapeutics Revenue by Region (2021-2026)
  5. 3.2.3 Global Liver Cirrhosis Therapeutics Revenue by Region (2027-2032)
  6. 3.2.4 Global Liver Cirrhosis Therapeutics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Liver Cirrhosis Therapeutics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Liver Cirrhosis Therapeutics Sales by Region
  9. 3.4.1 Global Liver Cirrhosis Therapeutics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Liver Cirrhosis Therapeutics Sales by Region (2021-2026)
  11. 3.4.3 Global Liver Cirrhosis Therapeutics Sales by Region (2027-2032)
  12. 3.4.4 Global Liver Cirrhosis Therapeutics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Liver Cirrhosis Therapeutics Revenue by Manufacturers
  2. 4.1.1 Global Liver Cirrhosis Therapeutics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Liver Cirrhosis Therapeutics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Liver Cirrhosis Therapeutics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Liver Cirrhosis Therapeutics Sales by Manufacturers
  6. 4.2.1 Global Liver Cirrhosis Therapeutics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Liver Cirrhosis Therapeutics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Liver Cirrhosis Therapeutics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Liver Cirrhosis Therapeutics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Liver Cirrhosis Therapeutics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Liver Cirrhosis Therapeutics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Liver Cirrhosis Therapeutics Manufacturers, Product Type & Application
  13. 4.7 Global Liver Cirrhosis Therapeutics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Liver Cirrhosis Therapeutics Market CR5 and HHI
  16. 4.8.2 2025 Liver Cirrhosis Therapeutics Tier 1, Tier 2, and Tier 3
5 Liver Cirrhosis Therapeutics Market by Type
  1. 5.1 Global Liver Cirrhosis Therapeutics Revenue by Type
  2. 5.1.1 Global Liver Cirrhosis Therapeutics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Liver Cirrhosis Therapeutics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Liver Cirrhosis Therapeutics Sales by Type
  6. 5.2.1 Global Liver Cirrhosis Therapeutics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Liver Cirrhosis Therapeutics Sales by Type (2021-2032) & (W Units)
  8. 5.2.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Liver Cirrhosis Therapeutics Price by Type
6 Liver Cirrhosis Therapeutics Market by Application
  1. 6.1 Global Liver Cirrhosis Therapeutics Revenue by Application
  2. 6.1.1 Global Liver Cirrhosis Therapeutics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Liver Cirrhosis Therapeutics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Liver Cirrhosis Therapeutics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Liver Cirrhosis Therapeutics Sales by Application
  6. 6.2.1 Global Liver Cirrhosis Therapeutics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Liver Cirrhosis Therapeutics Sales by Application (2021-2032) & (W Units)
  8. 6.2.3 Global Liver Cirrhosis Therapeutics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Liver Cirrhosis Therapeutics Price by Application
7 Company Profiles
  1. 7.1 Bristol-Myers Squibb
  2. 7.1.1 Bristol-Myers Squibb Company Information
  3. 7.1.2 Bristol-Myers Squibb Business Overview
  4. 7.1.3 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bristol-Myers Squibb Liver Cirrhosis Therapeutics Product Portfolio
  6. 7.1.5 Bristol-Myers Squibb Recent Developments
  7. 7.2 Conatus Pharmaceuticals
  8. 7.2.1 Conatus Pharmaceuticals Company Information
  9. 7.2.2 Conatus Pharmaceuticals Business Overview
  10. 7.2.3 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Conatus Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  12. 7.2.5 Conatus Pharmaceuticals Recent Developments
  13. 7.3 Gilead Sciences
  14. 7.3.1 Gilead Sciences Company Information
  15. 7.3.2 Gilead Sciences Business Overview
  16. 7.3.3 Gilead Sciences Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Gilead Sciences Liver Cirrhosis Therapeutics Product Portfolio
  18. 7.3.5 Gilead Sciences Recent Developments
  19. 7.4 Gwo Xi Stem Cell Applied Technology
  20. 7.4.1 Gwo Xi Stem Cell Applied Technology Company Information
  21. 7.4.2 Gwo Xi Stem Cell Applied Technology Business Overview
  22. 7.4.3 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Gwo Xi Stem Cell Applied Technology Liver Cirrhosis Therapeutics Product Portfolio
  24. 7.4.5 Gwo Xi Stem Cell Applied Technology Recent Developments
  25. 7.5 Instituto Grifols
  26. 7.5.1 Instituto Grifols Company Information
  27. 7.5.2 Instituto Grifols Business Overview
  28. 7.5.3 Instituto Grifols Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Instituto Grifols Liver Cirrhosis Therapeutics Product Portfolio
  30. 7.5.5 Instituto Grifols Recent Developments
  31. 7.6 Intercept Pharmaceuticals
  32. 7.6.1 Intercept Pharmaceuticals Company Information
  33. 7.6.2 Intercept Pharmaceuticals Business Overview
  34. 7.6.3 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Intercept Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  36. 7.6.5 Intercept Pharmaceuticals Recent Developments
  37. 7.7 NGM Biopharmaceuticals
  38. 7.7.1 NGM Biopharmaceuticals Company Information
  39. 7.7.2 NGM Biopharmaceuticals Business Overview
  40. 7.7.3 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 NGM Biopharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  42. 7.7.5 NGM Biopharmaceuticals Recent Developments
  43. 7.8 Norgine
  44. 7.8.1 Norgine Company Information
  45. 7.8.2 Norgine Business Overview
  46. 7.8.3 Norgine Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Norgine Liver Cirrhosis Therapeutics Product Portfolio
  48. 7.8.5 Norgine Recent Developments
  49. 7.9 Pharmicell
  50. 7.9.1 Pharmicell Company Information
  51. 7.9.2 Pharmicell Business Overview
  52. 7.9.3 Pharmicell Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Pharmicell Liver Cirrhosis Therapeutics Product Portfolio
  54. 7.9.5 Pharmicell Recent Developments
  55. 7.10 Salix Pharmaceuticals
  56. 7.10.1 Salix Pharmaceuticals Company Information
  57. 7.10.2 Salix Pharmaceuticals Business Overview
  58. 7.10.3 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Salix Pharmaceuticals Liver Cirrhosis Therapeutics Product Portfolio
  60. 7.10.5 Salix Pharmaceuticals Recent Developments
  61. 7.11 Stempeutics Research
  62. 7.11.1 Stempeutics Research Company Information
  63. 7.11.2 Stempeutics Research Business Overview
  64. 7.11.3 Stempeutics Research Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Stempeutics Research Liver Cirrhosis Therapeutics Product Portfolio
  66. 7.11.5 Stempeutics Research Recent Developments
  67. 7.12 GlaxoSmithKline
  68. 7.12.1 GlaxoSmithKline Company Information
  69. 7.12.2 GlaxoSmithKline Business Overview
  70. 7.12.3 GlaxoSmithKline Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 GlaxoSmithKline Liver Cirrhosis Therapeutics Product Portfolio
  72. 7.12.5 GlaxoSmithKline Recent Developments
  73. 7.13 Roche
  74. 7.13.1 Roche Company Information
  75. 7.13.2 Roche Business Overview
  76. 7.13.3 Roche Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Roche Liver Cirrhosis Therapeutics Product Portfolio
  78. 7.13.5 Roche Recent Developments
  79. 7.14 Merck
  80. 7.14.1 Merck Company Information
  81. 7.14.2 Merck Business Overview
  82. 7.14.3 Merck Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Merck Liver Cirrhosis Therapeutics Product Portfolio
  84. 7.14.5 Merck Recent Developments
  85. 7.15 Johnson & Johnson
  86. 7.15.1 Johnson & Johnson Company Information
  87. 7.15.2 Johnson & Johnson Business Overview
  88. 7.15.3 Johnson & Johnson Liver Cirrhosis Therapeutics Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Johnson & Johnson Liver Cirrhosis Therapeutics Product Portfolio
  90. 7.15.5 Johnson & Johnson Recent Developments
8 North America
  1. 8.1 North America Liver Cirrhosis Therapeutics Market Size by Type
  2. 8.1.1 North America Liver Cirrhosis Therapeutics Revenue by Type (2021-2032)
  3. 8.1.2 North America Liver Cirrhosis Therapeutics Sales by Type (2021-2032)
  4. 8.1.3 North America Liver Cirrhosis Therapeutics Price by Type (2021-2032)
  5. 8.2 North America Liver Cirrhosis Therapeutics Market Size by Application
  6. 8.2.1 North America Liver Cirrhosis Therapeutics Revenue by Application (2021-2032)
  7. 8.2.2 North America Liver Cirrhosis Therapeutics Sales by Application (2021-2032)
  8. 8.2.3 North America Liver Cirrhosis Therapeutics Price by Application (2021-2032)
  9. 8.3 North America Liver Cirrhosis Therapeutics Market Size by Country
  10. 8.3.1 North America Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Liver Cirrhosis Therapeutics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Liver Cirrhosis Therapeutics Market Size by Type
  2. 9.1.1 Europe Liver Cirrhosis Therapeutics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Liver Cirrhosis Therapeutics Sales by Type (2021-2032)
  4. 9.1.3 Europe Liver Cirrhosis Therapeutics Price by Type (2021-2032)
  5. 9.2 Europe Liver Cirrhosis Therapeutics Market Size by Application
  6. 9.2.1 Europe Liver Cirrhosis Therapeutics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Liver Cirrhosis Therapeutics Sales by Application (2021-2032)
  8. 9.2.3 Europe Liver Cirrhosis Therapeutics Price by Application (2021-2032)
  9. 9.3 Europe Liver Cirrhosis Therapeutics Market Size by Country
  10. 9.3.1 Europe Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Liver Cirrhosis Therapeutics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Liver Cirrhosis Therapeutics Market Size by Type
  2. 10.1.1 China Liver Cirrhosis Therapeutics Revenue by Type (2021-2032)
  3. 10.1.2 China Liver Cirrhosis Therapeutics Sales by Type (2021-2032)
  4. 10.1.3 China Liver Cirrhosis Therapeutics Price by Type (2021-2032)
  5. 10.2 China Liver Cirrhosis Therapeutics Market Size by Application
  6. 10.2.1 China Liver Cirrhosis Therapeutics Revenue by Application (2021-2032)
  7. 10.2.2 China Liver Cirrhosis Therapeutics Sales by Application (2021-2032)
  8. 10.2.3 China Liver Cirrhosis Therapeutics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Liver Cirrhosis Therapeutics Market Size by Type
  2. 11.1.1 Asia Liver Cirrhosis Therapeutics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Liver Cirrhosis Therapeutics Sales by Type (2021-2032)
  4. 11.1.3 Asia Liver Cirrhosis Therapeutics Price by Type (2021-2032)
  5. 11.2 Asia Liver Cirrhosis Therapeutics Market Size by Application
  6. 11.2.1 Asia Liver Cirrhosis Therapeutics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Liver Cirrhosis Therapeutics Sales by Application (2021-2032)
  8. 11.2.3 Asia Liver Cirrhosis Therapeutics Price by Application (2021-2032)
  9. 11.3 Asia Liver Cirrhosis Therapeutics Market Size by Country
  10. 11.3.1 Asia Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Liver Cirrhosis Therapeutics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Liver Cirrhosis Therapeutics Market Size by Type
  2. 12.1.1 SAMEA Liver Cirrhosis Therapeutics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Liver Cirrhosis Therapeutics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Liver Cirrhosis Therapeutics Price by Type (2021-2032)
  5. 12.2 SAMEA Liver Cirrhosis Therapeutics Market Size by Application
  6. 12.2.1 SAMEA Liver Cirrhosis Therapeutics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Liver Cirrhosis Therapeutics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Liver Cirrhosis Therapeutics Price by Application (2021-2032)
  9. 12.3 SAMEA Liver Cirrhosis Therapeutics Market Size by Country
  10. 12.3.1 SAMEA Liver Cirrhosis Therapeutics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Liver Cirrhosis Therapeutics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Liver Cirrhosis Therapeutics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Liver Cirrhosis Therapeutics Value Chain Analysis
  2. 13.1.1 Liver Cirrhosis Therapeutics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Liver Cirrhosis Therapeutics Production Mode & Process
  6. 13.2 Liver Cirrhosis Therapeutics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Liver Cirrhosis Therapeutics Distributors
  9. 13.2.3 Liver Cirrhosis Therapeutics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst